LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 94.68 | 17.25 | 7146 | 6239 | 1.1453 | 1.0322 | MN20160310_N02 | N07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 3.06 | 17.25 | 457 | 143 | 3.1910 | 1.9246 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 3.06 | 17.25 | 463 | 143 | 3.2329 | 1.9372 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 5.03 | 17.25 | 774 | 273 | 2.8315 | 1.5968 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 5.03 | 17.25 | 792 | 273 | 2.8973 | 1.6118 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.01 | 17.25 | 920 | 389 | 2.3620 | 1.4213 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.01 | 17.25 | 966 | 389 | 2.4801 | 1.4477 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.98 | 17.25 | 994 | 445 | 2.2333 | 1.3738 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.98 | 17.25 | 1048 | 445 | 2.3547 | 1.4007 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.95 | 17.25 | 1035 | 471 | 2.1948 | 1.3581 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.95 | 17.25 | 1129 | 471 | 2.3941 | 1.4014 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.91 | 17.25 | 1106 | 494 | 2.2350 | 1.3614 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.91 | 17.25 | 1167 | 494 | 2.3583 | 1.3877 | MN20160310_N02 | N15 |